ATE435025T1 - Hemmung des tumorwachstums und der metastasenbildung mit von atf2 stammenden peptiden - Google Patents

Hemmung des tumorwachstums und der metastasenbildung mit von atf2 stammenden peptiden

Info

Publication number
ATE435025T1
ATE435025T1 AT05810019T AT05810019T ATE435025T1 AT E435025 T1 ATE435025 T1 AT E435025T1 AT 05810019 T AT05810019 T AT 05810019T AT 05810019 T AT05810019 T AT 05810019T AT E435025 T1 ATE435025 T1 AT E435025T1
Authority
AT
Austria
Prior art keywords
atf2
inhibition
therapies
tumor growth
peptides derived
Prior art date
Application number
AT05810019T
Other languages
English (en)
Inventor
Anindita Bhoumik
Ze Ev Ronai
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE435025T1 publication Critical patent/ATE435025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05810019T 2004-10-18 2005-10-17 Hemmung des tumorwachstums und der metastasenbildung mit von atf2 stammenden peptiden ATE435025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62018404P 2004-10-18 2004-10-18
PCT/US2005/037634 WO2006044984A1 (en) 2004-10-18 2005-10-17 Inhibition of tumor growth and metastasis by atf2-derived peptides

Publications (1)

Publication Number Publication Date
ATE435025T1 true ATE435025T1 (de) 2009-07-15

Family

ID=35695674

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810019T ATE435025T1 (de) 2004-10-18 2005-10-17 Hemmung des tumorwachstums und der metastasenbildung mit von atf2 stammenden peptiden

Country Status (6)

Country Link
US (1) US20090281025A1 (de)
EP (1) EP1809315B1 (de)
AT (1) ATE435025T1 (de)
CA (1) CA2595669A1 (de)
DE (1) DE602005015241D1 (de)
WO (1) WO2006044984A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007047093B4 (de) * 2007-10-01 2010-07-01 Ferton Holding S.A. Vorrichtung zur Messung von Fluoreszenzstrahlung an biologischen Substanzen mit einer Halbleitersensorenanordnung
US20110129844A1 (en) * 2007-12-21 2011-06-02 Ronai Ze Ev Use of Activating Transcription Factor-2 (ATF2) for Detecting Skin Cancer

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) * 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) * 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4861719A (en) * 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4980289A (en) * 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
ATE243754T1 (de) * 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
US5783682A (en) * 1990-07-27 1998-07-21 Isis Pharmaceuticals, Inc. Oligonucleotide mimics having nitrogen-containing linkages
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
AU7286696A (en) * 1995-10-13 1997-05-07 F. Hoffmann-La Roche Ag Antisense oligomers
US5677684A (en) * 1996-08-26 1997-10-14 Mcarthur; Evan B. Emergency vehicle sound-actuated traffic controller
US5814500A (en) * 1996-10-31 1998-09-29 The Johns Hopkins University School Of Medicine Delivery construct for antisense nucleic acids and methods of use
WO2002064025A2 (en) * 2001-02-15 2002-08-22 Mount Sinai School Of Medicine Of New York University Inhibition of atf2 activity to treat cancer

Also Published As

Publication number Publication date
US20090281025A1 (en) 2009-11-12
CA2595669A1 (en) 2006-04-27
EP1809315B1 (de) 2009-07-01
WO2006044984A1 (en) 2006-04-27
EP1809315A1 (de) 2007-07-25
DE602005015241D1 (de) 2009-08-13

Similar Documents

Publication Publication Date Title
Le Saux et al. Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer
EP2520652A3 (de) Krebszellenspezifische Apoptoseinduktoren, die auf mit Chromosomenstabilisierung in Zusammenhang stehende Gene abzielen
Lu et al. TP53 dysfunction in diffuse large B-cell lymphoma
AU2018256605A1 (en) Benzoquinone Derivative E3330 in Combination with Chemotherapeutic Agents for the Treatment of Cancer and Angiogenesis
WO2009049214A3 (en) Inhibition and treatment of prostate cancer metastasis
DE602006014843D1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
NO20070324L (no) Forbindelser og fremgangsmater for inhibering av BCL proteiner med bindingspartnere
JO2917B1 (en) Compounds and methods to inhibit the interaction between BCL and binding partners
WO2008005954A3 (en) Tryphostin-analogs for the treatment of cell proliferative diseases
DE602007012677D1 (de) Verfahren zur behandlung von zellproliferationsstörungen mit pyrimidindiaminverbindungen
WO2011159685A3 (en) Inhibition of wdr5 interaction with its binding partners and therapeutic methods
MX2010005768A (es) Composiciones y métodos para inhibir la activación del arnbc-dependiente de la proteina de la kinasa y la inhibición del crecimiento tumoral.
Huang et al. MiR-99a inhibits cell proliferation and tumorigenesis through targeting mTOR in human anaplastic thyroid cancer
WO2010042933A3 (en) Inhibition and treatment of prostate cancer metastasis
WO2017132291A8 (en) Genetic, developmental and micro-environmental programs in idh-mutant gliomas, compositions of matter and methods of use thereof
DK1755659T3 (da) Anvendelse af anti-alfa5beta1-antistoffer til inhibering af kræftcelleproliferation
Verim et al. Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey
DE69722621D1 (de) Inhibierung von dns reparatur zur erhöhung der sensitivität für p53-vermittelte suppression
Wang et al. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma
ATE435025T1 (de) Hemmung des tumorwachstums und der metastasenbildung mit von atf2 stammenden peptiden
DE602005024021D1 (de) GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoA
Singh et al. Induction of CaSR expression circumvents the molecular features of malignant CaSR null colon cancer cells
MY153232A (en) Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
WO2007123777A3 (en) Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
Midorikawa et al. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties